Baxalta drops, CTI nosedives after patient deaths & adverse events prompt FDA partial hold

Baxalta drops, CTI nosedives after patient deaths & adverse events prompt FDA partial hold

Submitted by admin on February 8, 2016 - 10:24am
Source: 
BioPharma Dive
News Tags: 
Baxalta
Shire
CTI BioPharma
pacritinib
JAK inhibitors
Headline: 
Baxalta drops, CTI nosedives after patient deaths & adverse events prompt FDA partial hold

Do Not Allow Advertisers to Use My Personal information